Value of ₹10,000 invested on 30 Oct 2016, month by month.
| Where | Worth now | Change | Against AUROPHARMA |
|---|---|---|---|
| Aurobindo Pharma | ₹20,554 | +105.5% | — |
| NIFTY 50 | ₹26,726 | +167.3% | ₹6,172 less |
| Fixed deposit at 6.5% | ₹18,770 | +87.7% | ₹1,784 more |
The NIFTY 50 figure is the index itself over the same dates, which like this page counts price only and no dividends — so the two are measured the same way. The fixed deposit line assumes a steady 6.5% a year for the whole period. No bank held one rate that long: Indian deposit rates ran from around 9% in 2014 to about 5.5% in 2021. Treat it as a yardstick, not a record of what a deposit actually paid.
| Year | Change |
|---|---|
| 2026 | +42.1% |
| 2025 | -11.4% |
| 2024 | +23.1% |
| 2023 | +147.3% |
| 2022 | -40.3% |
| 2021 | -20.3% |
₹10,000 at ₹818.05 a share buys 12.22 shares. Held to the close of 30 Oct 2026 at ₹1,681, those shares are worth ₹20,554. Dividends are not included, and neither are brokerage, taxes or charges — the real figure would differ on both counts.
Data covers 19 May 2016 to 30 Oct 2026 (2,588 trading days), from end-of-day NSE prices. This page is a record of what prices did. It is not advice, and nothing here is a recommendation to buy or sell — read the disclaimer.